Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NIRSEVIMAB vs NITROFURANTOIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

NIRSEVIMAB vs NITROFURANTOIN: Safety Overview

Metric NIRSEVIMAB NITROFURANTOIN
Total FAERS Reports 247 5,073
Deaths Reported 5 256
Death Rate 2.0% 5.0%
Hospitalizations 149 1,615
Average Patient Age 0.3 yrs 61.4 yrs
% Female Patients 42.3% 87.9%
FDA Approval Date N/A Approved Prior to Jan 1, 1982
Manufacturer Sanofi Pasteur Inc. Proficient Rx LP
Route INTRAMUSCULAR ORAL
Marketing Status N/A Discontinued